Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
40,31 USD | -1,80% |
|
-1,59% | -4,93% |
Attività
Numero di dipendenti: 355
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Ronald Renaud
CEO | Chief Executive Officer | 55 | 12/06/23 |
Director of Finance/CFO | 42 | 15/05/23 | |
N. Coles
CHM | Chairman | 63 | 01/12/18 |
Raymond Sanchez
CTO | Chief Tech/Sci/R&D Officer | 63 | 01/01/19 |
John Renger
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/05/19 |
53 | - | ||
Matthew Calistri
IRC | Investor Relations Contact | - | - |
Scott Akamine
LAW | General Counsel | 40 | 24/05/21 |
Mark Bodenrader
AUD | Comptroller/Controller/Auditor | 51 | 01/09/19 |
Paul Burgess
PRN | Corporate Officer/Principal | 50 | 20/06/23 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Director/Board Member | 63 | 01/06/19 | |
Douglas Giordano
BRD | Director/Board Member | 61 | 01/09/18 |
Ruth McKernan
BRD | Director/Board Member | 66 | 04/12/20 |
Deval Patrick
BRD | Director/Board Member | 67 | 20/01/21 |
Marijn Dekkers
BRD | Director/Board Member | 65 | 01/09/18 |
Norbert Riedel
BRD | Director/Board Member | 66 | 01/12/18 |
N. Coles
CHM | Chairman | 63 | 01/12/18 |
Ronald Renaud
CEO | Chief Executive Officer | 55 | 12/06/23 |
Director/Board Member | 51 | 01/09/18 | |
Adam Koppel
BRD | Director/Board Member | 54 | 01/09/18 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 182 194 722 | 77 396 713 ( 42,48 %) | 0 | 42,48 % |
Coordinate società
Cerevel Therapeutics Holdings, Inc.
222 Jacobs Street Suite 200
02141, Cambridge
+844 304 2048
http://www.cerevel.com![Indirizzo Cerevel Therapeutics Holdings, Inc.(CERE)](https://cdn.zonebourse.com/static/address/110370301.png)
Settore
![Consenso](/images/consensus_flch.gif)
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-4,93% | 7,48 Mrd | |
+20,12% | 127 Mrd | |
+25,25% | 117 Mrd | |
+25,56% | 27,77 Mrd | |
-19,51% | 20,44 Mrd | |
-14,36% | 16,62 Mrd | |
-15,63% | 15,92 Mrd | |
-46,67% | 14,94 Mrd | |
+11,89% | 14,74 Mrd | |
+57,74% | 14,38 Mrd |
- Borsa valori
- Azioni
- Azione CERE
- Società Cerevel Therapeutics Holdings, Inc.